SCHEMBL27101467

SCHEMBL27101467

c1ccc(-c2nc(-c3ccc(-c4cccc5ccccc45)cc3)nc(-c3cc(-c4ccccc4)c4oc5cc6ccccc6cc5c4c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ ATM Q13315 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ENPP3 O14638 1/20 0.37
▸ ENPP1 P22413 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24066098 1.00 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL29298628 0.95 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL25666485 0.93 ENPP1 (0.41) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL24586401 0.93 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL24066231 0.93 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL24066091 0.92 ENPP3 (0.40) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL25708412 0.91 MAPT (0.36) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL24066103 0.91 MAPT (0.36) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL29298626 0.91 NUDT1 (0.37) ALDH1A1MAPTKDM4EHSD17B10ATM
SCHEMBL29298622 0.91 ALDH1A1 (0.39) ALDH1A1MAPTKDM4EHSD17B10ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-02-29 — — US disclosed
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, WEE1 ALDH1A1 87/4885MAPT 1259/4885KDM4E 2624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback